Invitation to Immunovia's Q2 presentation
/PRNewswire/ -- Immunovia will publish its second quarter 2022 results on August 24, 2022 at 8:30 am CET. Analysts, investors and media are invited to a...
Source: prnewswire.com
📰 Philipp Mathieu News
Page 6 - Philipp Mathieu News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Philipp Mathieu. Real-time updates on events, politics, business and more.
Immunovia, Inc. Issued Clinical and Public Health Laboratory License from California Dept of Public Health for IMMray™ PanCan-d test
/PRNewswire/ -- The California Department of Public Health has granted Immunovia, Inc., the American subsidiary of Immunovia AB (Nasdaq :IMMNOV) (Stockholm:...
United States Immray Pancan D Karin Almqvist Liwendahl Jeff Borcherding Philipp Mathieu Immunovia Inc
Source: prnewswire.com
Immunovia AB: Immunovia, Inc. Issued Clinical and Public Health Laboratory License from California Dept of Public Health for IMMray PanCan-d test
LUND, Sweden, Aug. 11, 2022 /PRNewswire/ -- The California Department of Public Health has granted Immunovia, Inc., the American subsidiary of Immunovia AB (Nasdaq :IMMNOV) (Stockholm: IMMNOV)
United States Immray Pancan D Karin Almqvist Liwendahl Jeff Borcherding Philipp Mathieu Immunovia Inc
Source: finanznachrichten.de
Immunovia, Inc. Issued Clinical and Public Health Laboratory License from California Dept of Public Health for IMMray™ P
LUND, Sweden, Aug. 11, 2022 /PRNewswire/ -- The California Department of Public Health has granted...
United States Immray Pancan D Karin Almqvist Liwendahl Jeff Borcherding Philipp Mathieu Immunovia Inc
Source: europapress.es
Immunovia: CPT PLA Code for the IMMray™ PanCan-d test approved
/PRNewswire/ -- Immunovia AB (NASDAQ Stockholm: IMMNOV) announced, that Immunovia, Inc., its American subsidiary, has recently received approval for a Current...
United States Philipp Mathieu Laboratory Analyses Centers Of Medicare Medicaid Services Editorial Panel American Medical Association
Source: prnewswire.com
The PanDIA-1 study, for early detection of pancreatic cancer in newly onset type 2 diabetics, moves into next phase
/PRNewswire/ -- Immunovia today announced the PanDIA-1 study for the early detection of pancreatic cancer in newly onset type 2 diabetics is moving into the...
United States Prnewswire Immunovia Philipp Mathieu Immunovia Inc Corporate Communications Lund University Diabetes Center
Source: prnewswire.com
PanFAM-1 Results Partly Inconclusive
/PRNewswire/ -- Immunovia today announced results from the PanFAM-1 study. The PanFAM-1 study is a prospective, multi-center, investigational study, designed...
United States United Kingdom Prnewswire Immunovia Philipp Mathieu Immunovia Inc Corporate Communications
Source: prnewswire.com
Immunovia, Inc. market access increases when achieving Clinical Laboratory Permits from Pennsylvania and Maryland Departments of Health making IMMray™ PanCan-d test available in 48 US states
/PRNewswire/ -- The Pennsylvania and Maryland Departments of Health have granted Immunovia, Inc., the US subsidiary of Immunovia AB (Nasdaq Stockholm: IMMNOV),...
United States Jeff Borcherding Philipp Mathieu Immunovia Inc Corporate Communications Clinical Laboratory
Source: prnewswire.com
Immunovia, Inc. market access increases when achieving Clinical Laboratory Permits from Pennsylvania and Maryland Depart
LUND, Sweden, May 23, 2022 /PRNewswire/ -- The Pennsylvania and Maryland Departments of Health have granted...
United States Jeff Borcherding Philipp Mathieu Immunovia Inc Clinical Laboratory Maryland Departments Of Health
Source: europapress.es
Immunovia AB: Immunovia, Inc. achieves Clinical Laboratory Licensure from Rhode Island Dept of Health making IMMray PanCan-d test available in 46 US states
LUND, Sweden, May 17, 2022 /PRNewswire/ -- The Rhode Island Department of Health has granted Immunovia, Inc., the US subsidiary of Immunovia AB (Nasdaq Stockholm: IMMNOV), Clinical Laboratory
Rhode Island United States Immray Pancan D Jeff Borcherding Philipp Mathieu Rhode Island Department Of Health
Source: finanznachrichten.de